91 related articles for article (PubMed ID: 2439598)
1. Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist.
Solovera JJ; Alvarez-Mon M; Casas J; Carballido J; Durantez A
J Immunol; 1987 Aug; 139(3):876-80. PubMed ID: 2439598
[TBL] [Abstract][Full Text] [Related]
2. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent natural killer and calcium-independent natural cytotoxic activities in an IL-2-dependent killer cell line.
Richards AL; Djeu JY
J Immunol; 1990 Nov; 145(9):3144-9. PubMed ID: 2120346
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
5. The action of calcium antagonists in the human natural killer cell-mediated cytotoxicity.
Waschke K; von Baehr R; Wolf G
Allerg Immunol (Leipz); 1987; 33(1):27-34. PubMed ID: 2954444
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
Sayers TJ; Mason AT; Ortaldo JR
J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
8. Potassium channels in human NK cells are involved in discrete stages of the killing process.
Sidell N; Schlichter LC; Wright SC; Hagiwara S; Golub SH
J Immunol; 1986 Sep; 137(5):1650-8. PubMed ID: 2427578
[TBL] [Abstract][Full Text] [Related]
9. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
[TBL] [Abstract][Full Text] [Related]
10. Calcium and the endothelin-1 and alpha 1-adrenergic stimulated phosphatidylinositol cycle in cultured rat cardiomyocytes.
van Heugten HA; de Jonge HW; Bezstarosti K; Lamers JM
J Mol Cell Cardiol; 1994 Aug; 26(8):1081-93. PubMed ID: 7528283
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
12. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
13. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
15. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
Cordero OJ; Sarandeses CS; López JL; Nogueira M
Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Ca2+-dependent pathways in the inhibition of human natural killer (NK) cell activity by cortisol.
Masera R; Gatti G; Sartori ML; Carignola R; Salvadori A; Magro E; Angeli A
Immunopharmacology; 1989; 18(1):11-22. PubMed ID: 2475455
[TBL] [Abstract][Full Text] [Related]
17. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
